LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Acute graft-versus-host disease (GVHD) and leukemic relapse remain the two major obstacles to successful outcomes after allogeneic bone marrow transplantation (BMT). Recent studies have demonstrated that the loss of gastrointestinal tract integrity, and specifically the translocation of LPS into the systemic circulation, is critical to the induction of cytokine dysregulation that contributes to GVHD. Using a mouse BMT model, we studied the effects of direct LPS antagonism on GVHD severity and graft-versus-leukemia (GVL) activity. Administration of B975, a synthetic lipid-A analogue from day 0 to day +6, reduced serum TNF-alpha levels, decreased intestinal histopathology, and resulted in significantly improved survival and a reduction in clinical GVHD, compared with control-treated animals. Importantly, B975 had no effect on donor T cell responses to host antigens in vivo or in vitro. When mice received lethal doses of P815 tumor cells at the time of BMT, administration of B975 did not impair GVL activity and resulted in significantly improved leukemia-free survival. These findings reveal a critical role for LPS in the early inflammatory events contributing to GVHD and suggest that a new class of pharmacologic agents, LPS antagonists, may help to prevent GVHD while preserving T cell responses to host antigens and GVL activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goycoolea, A. (1997) · Cited by 3,615
Bone marrow transplant: Angela Joyce on the care of children undergoing BMT for genetic disorders
Joyce, A. (1989) · Paediatric Nursing · doi:10.7748/paed.1.6.21.s21 · Cited by 3,384
Szer, J. (1999) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1999.tb127745.x · Cited by 3,353
Graft-versus-leukemia reactions after bone marrow transplantation
Horowitz, M., Gale, R., Sondel, P., Goldman, J., Kersey, J., Kolb, H., Rimm, A., Ringden, O., Rozman, C., & Speck, B. (1990) · Blood · doi:10.1182/blood.v75.3.555.555 · Cited by 2,774
Ford, R., & Eisenberg, S. (1990) · Nursing Clinics of North America · doi:10.1016/s0029-6465(22)02934-6 · Cited by 2,720
Raetz, C. R. H. (1990) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.59.070190.001021 · Cited by 1,230
Ferrara, J. L. M., & Deeg, H. J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103073241005 · Cited by 1,219
Self-citationENDOTOXINS AND DISEASE MECHANISMS
Morrison, D. C., & Ryan, J. L. (1987) · Annual Review of Medicine · doi:10.1146/annurev.me.38.020187.002221 · Cited by 1,103
Cooke, K., Kobzik, L., Martin, T., Brewer, J., Delmonte, J. J., Crawford, J., & Ferrara, J. (1996) · Blood · doi:10.1182/blood.v88.8.3230.bloodjournal8883230 · Cited by 963
Self-citationHill, G. R., Crawford, J. M., Cooke, K. R., Brinson, Y. S., Pan, L., & Ferrara, J. L. M. (1997) · Blood · doi:10.1182/blood.v90.8.3204 · Cited by 832
Self-citationBrodie, S. E. (1996) · Survey of Ophthalmology · doi:10.1016/s0039-6257(96)80075-0 · Cited by 745
Hill, G. R., & Ferrara, J. L. M. (2000) · Blood · doi:10.1182/blood.v95.9.2754.009k25_2754_2759 · Cited by 715
Self-citationPiguet, P. F., Grau, G. E., Allet, B., & Vassalli, P. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.5.1280 · Cited by 584
Holler, E., Kolb, H., Moller, A., Kempeni, J., Liesenfeld, S., Pechumer, H., Lehmacher, W., Ruckdeschel, G., Gleixner, B., & Riedner, C. (1990) · Blood · doi:10.1182/blood.v75.4.1011.1011 · Cited by 577
Storb, R., Prentice, R. L., Buckner, C. D., Clift, R. A., Appelbaum, F., Deeg, J., Doney, K., Hansen, J. A., Mason, M., Sanders, J. E., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198302103080602 · Cited by 431
Nestel, F. P., Price, K. S., Seemayer, T. A., & Lapp, W. S. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.2.405 · Cited by 365
T Cell Stimulation In Vivo by Lipopolysaccharide (LPS)
Tough, D. F., Sun, S., & Sprent, J. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.12.2089 · Cited by 343
Cooke, K. R., Hill, G. R., Crawford, J. M., Bungard, D., Brinson, Y. S., Delmonte, J., & Ferrara, J. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4285 · Cited by 335
Self-citationBekkum, D. W. V., Roodenburg, J., Heidt, P. J., & Waaij, D. V. D. (1974) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/52.2.401 · Cited by 330
E5531, a Pure Endotoxin Antagonist of High Potency
Christ, W. J., Asano, O., Robidoux, A. L. C., Perez, M., Wang, Y., Dubuc, G. R., Gavin, W. E., Hawkins, L. D., McGuinness, P. D., Mullarkey, M. A., et al. (1995) · Science · doi:10.1126/science.7701344 · Cited by 318
Self-citationBeelen, D. W., Elmaagacli, A., Müller, K.-D., Hirche, H., & Schaefer, U. W. (1999) · Blood · doi:10.1182/blood.v93.10.3267.410k22_3267_3275 · Cited by 270
Hill, G. R., Cooke, K. R., Teshima, T., Crawford, J. M., Keith, J. C., Brinson, Y. S., Bungard, D., & Ferrara, J. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3132 · Cited by 268
Self-citationPape, K. A., Khoruts, A., Mondino, A., & Jenkins, M. K. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.2.591 · Cited by 250
Differential roles of IL-1 and TNF-α on graft-versus-host disease and graft versus leukemia
Hill, G. R., Teshima, T., Gerbitz, A., Pan, L., Cooke, K. R., Brinson, Y. S., Crawford, J. M., & Ferrara, J. L. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6896 · Cited by 249
Self-citationHattori, K., Hirano, T., Miyajima, H., Yamakawa, N., Tateno, M., Oshimi, K., Kayagaki, N., Yagita, H., & Okumura, K. (1998) · Blood · doi:10.1182/blood.v91.11.4051 · Cited by 217
CYTOKINE CASCADES IN ACUTE GRAFT-VERSUS-HOST DISEASE1
Krenger, W., Hill, G. R., & Ferrara, J. L. M. (1997) · Transplantation · doi:10.1097/00007890-199708270-00001 · Cited by 206
Self-citationEissner, G., Kohlhuber, F., Grell, M., Ueffing, M., Scheurich, P., Hieke, A., Multhoff, G., Bornkamm, G., & Holler, E. (1995) · Blood · doi:10.1182/blood.v86.11.4184.bloodjournal86114184 · Cited by 199
Krenger, W., Snyder, K. M., Byon, J. C., Falzarano, G., & Ferrara, J. L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.2.585 · Cited by 187
Self-citationKeratinocyte Growth Factor Separates Graft-Versus-Leukemia Effects From Graft-Versus-Host Disease
Krijanovski, O. I., Hill, G. R., Cooke, K. R., Teshima, T., Crawford, J. M., Brinson, Y. S., & Ferrara, J. L. M. (1999) · Blood · doi:10.1182/blood.v94.2.825 · Cited by 179
Self-citationTeshima, T., Hill, G. R., Pan, L., Brinson, Y. S., van den Brink, M. R. M., Cooke, K. R., & Ferrara, J. L. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7111 · Cited by 174
Self-citationVella, A. T., Mitchell, T., Groth, B., Linsley, P. S., Green, J. M., Thompson, C. B., Kappler, J. W., & Marrack, P. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.10.4714 · Cited by 148
Role of Bacterial Microflora in Development of Intestinal Lesions From Graft-Versus-Host Reaction
van Bekkum, D. W., & Knaan, S. (1977) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/58.3.787 · Cited by 147
Tsukada, N., Kobata, T., Aizawa, Y., Yagita∥, H., & Okumura, K. (1999) · Blood · doi:10.1182/blood.v93.8.2738 · Cited by 144
Fowler, D. H., Kurasawa, K., Husebekk, A., Cohen, P. A., & Gress, R. E. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.3.1004 · Cited by 134
Vossen, J. M. J. J., Heidt, P. J., van den Berg, H., Gerritsen, E. J. A., Hermans, J., & Dooren, L. J. (1990) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01969527 · Cited by 133
Beelen, D., Haralambie, E., Brandt, H., Linzenmeier, G., Muller, K., Quabeck, K., Sayer, H., Graeven, U., Mahmoud, H., & Schaefer, U. (1992) · Blood · doi:10.1182/blood.v80.10.2668.2668 · Cited by 128
Bortin, M. M. (1974) · Clinical immunobiology · doi:10.1016/b978-0-12-070002-8.50016-3 · Cited by 95
Bunnell, E., Lynn, M., Habet, K., Neumann, A., Perdomo, C. A., Friedhoff, L. T., Rogers, S. L., & Parrillo, J. E. (2000) · Critical Care Medicine · doi:10.1097/00003246-200008000-00005 · Cited by 82
Jackson, S. K., Parton, J., Barnes, R. A., Poynton, C., & Fegan, C. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb00963.x · Cited by 58
Heidt, P. J., & Vossen, J. M. J. J. (1992) · PubMed · Cited by 53
Use of IgM enriched intravenous immunoglobulin (Pentaglobin) in bone marrow transplantation.
Poynton, C. H., Jackson, S. K., Fegan, C., Barnes, R. A., & Whittaker, J. A. (1992) · PubMed · Cited by 42
Anti-endotoxin antibody for prevention of acute GVHD.
Bayston, K. F., Jd, B., Clark, P., & Cohen, J. (1991) · PubMed · Cited by 16
Cited by
Ferrara, J. L., Levine, J. E., Reddy, P., & Holler, E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60237-3 · Cited by 2,464
Self-citationShono, Y., Docampo, M. D., Peled, J. U., Perobelli, S. M., Velardi, E., Tsai, J. J., Slingerland, A. E., Smith, O. M., Young, L. F., Gupta, J., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf2311 · Cited by 592
Microbial Translocation in the Pathogenesis of HIV Infection and AIDS
Marchetti, G., Tincati, C., & Silvestri, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00050-12 · Cited by 500
A porous defense: the leaky epithelial barrier in intestinal disease
Clayburgh, D. R., Shen, L., & Turner, J. R. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700050 · Cited by 498
Estes, J. D., Harris, L. D., Klatt, N. R., Tabb, B., Pittaluga, S., Paiardini, M., Barclay, G. R., Smedley, J., Pung, R., Oliveira, K. M., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001052 · Cited by 477
Metadata
- Authors
- Cooke, K. R., Gerbitz, A., Crawford, J. M., Teshima, T., Hill, G. R., Tesolin, A., Rossignol, D. P., & Ferrara, J. L. M.
- Venue
- Journal of Clinical Investigation
- Published
- 2001-06-15
- Volume
- 107
- Issue
- 12
- Pages
- 1581-1589
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2155940448
- Cited by
- 291
- References
- 42
- FWCI
- 9.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.